Organic phosphorescence materials with longlived triplet excitons that can highly generate active singlet oxygen ( 1 O 2 ) through the energy transfer with the molecular oxygen under photoexcitation, serve as highly efficient antibacterial agent. Herein, we report bright red-emissive organic phosphorescent nanoparticles (PNPs) based on a metal-free organic phosphor encapsulated with biocompatible block copolymers. The obtained PNPs with an ultra-small particle size of around 5 nm and a long emission lifetime of up to 167 μs showed effective 1 O 2 generation ability under visible light (410 nm) excitation in aqueous media, which can efficiently eradicate multi-drug resistant bacteria both in vitro and in vivo. This is the first demonstration of metal-free organic PNPs for photodynamic antimicrobial therapy, expanding the application scope of metal-free organic room temperature phosphorescent materials.
INTRODUCTION
Organic phosphorescence materials, owing to their long phosphorescence lifetime, tunable emission color, excellent stabilities and high quantum efficiency, have attracted great attention in optoelectronic fields such as organic light-emitting diodes (OLEDs) [1] , bioelectronic fileds such as bio-imaging [2,3] and photodynamic cancer therapy [4] , as well as photonics fields such as chemical sensors [5] [6] [7] [8] , anti-counterfeiting [9, 10] , and so on [11, 12] . In previous years, organic phosphorescent ma-terials are largely limited to organometallic luminogens, such as Pt(II)-, Ru(III)-, Ir(III)-complexes, because the efficient spin-orbit coupling (SOC) induced by the heavymetal effect can promote phosphorescence emission [13, 14] . However, recent attention has been transferred to metal-free organic phosphorescent materials on account of the drawbacks of the noble metals, such as high cost, high toxicity and scarce resource [15, 16] . Different from organometallic luminogens, metal-free organic compounds are easier to synthesize, more stable and modifiable in molecular structures. Therefore, great efforts have been devoted to developing purely organic phosphorescence through various feasible strategies in recent years, including H-aggregation [17] [18] [19] [20] [21] [22] [23] [24] , crystal engineering [25] [26] [27] [28] [29] , host-guest doping [30] [31] [32] [33] , polymerization [34] [35] [36] [37] and so on [38] [39] [40] [41] . Since previously reported metal-free organic room temperature phosphorescent materials are almost bulk crystals or powders, it is still a formidable challenge to develop the application of such materials in the bio-medical fields [2, 3] .
In recent years, the emerging antibiotic-resistant bacteria have posed a serious threat to public health [42, 43] . From 2005 to 2016, the incidence of hospital-onset and community-onset methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection has reached 74% and 40%, respectively. To crack this antibiotic-resistance crisis, various novel antimicrobials were proposed recently, including host defense peptides [44, 45] , immunomodulators [46] , bacteriophages [47] , silver nanoagents [48] , etc. However, inherent drawbacks like sophistication, high cost, and unpredictable threats to human health (e.g., cellular toxicity, skin staining, allergic reactions) impeded their biomedical applications [49] [50] [51] [52] . Therefore, facilely prepared non-toxic antimicrobial agents with potent biocidal efficacy towards multidrugresistant bacteria are in urgent demand.
As we all know, reactive oxygen species (ROS) are commonly used as antibacterial agents because of their broad-spectrum sterilization ability [53] [54] [55] . Actually, the electrons of organic phosphorescence materials are excited from the ground state (S 0 ) to their first singlet excited state (S 1 ) under the photoexcitation, and then singlet excitons undergo a spin conversion and transfer into the triplet state (T 1 ). Subsequently, energy transfer between T 1 state and the ground state (triplet state) of molecular oxygen in the air occurs, resulting in the generation of singlet oxygen ( 1 O 2 ) via the process of triplet-triplet annihilation (TTA) [5] . As one type of the ROS, the 1 O 2 can not only increase the permeability to the bacterial membrane, causing substances outflow and loss of bacterial activity, but also directly damage the nucleotides or DNA repair enzymes to further kill bacteria [56, 57] . Therefore, organic phosphorescence materials could be considered as novel efficient antimicrobial agents.
Here, we report a class of water-soluble metal-free phosphorescent nanoparticles (PNPs) that could effectively eliminate clinically significant "superbug" MRSA multidrug-resistant bacteria both in vitro and in vivo for the first time. In this work, PNPs with an ultrasmall particle size of less than 5 nm were prepared by encapsulating metal-free organic phosphor, (4,7-dibromo-5, 6-di(9H-carbazol-9-yl)benzo[c][1,2,5] thiadiazole, DBCz-BT) with biocompatible amphiphilic copolymers by a top-down method [3] . The energy transfer between the triplet state of the PNPs and the molecular oxygen in the air (triplet state) could result in the production of 1 O 2 that can efficiently kill microorganisms under visible light illumination ( Fig. 1a ). This study will provide a new platform for extending the application of pure organic room temperature phosphorescent materials in photodynamic therapy for infections.
EXPERIMENTAL SECTION

Materials
Unless otherwise noted, all reagents used in the experiments were purchased from commercial sources without further purification. The bright red organic phosphorescent molecule (DBCz-BT) was synthesized according to previous studies. Phosphate buffered saline (PBS) obtained from Sigma-Aldrich was autoclaved at 121°C for sterilization before use. The LIVE/DEAD BacLight Bacterial Viability kit and the LIVE/DEAD Viability kit for mammalian cells were purchased from Thermo Fisher Scientific (USA). Luria-Bertani (LB) agar was purchased from Oxoid (USA). Bacteria strains (E. coli ATCC25922 and MRSA ATCC BAA40) were obtained from American Type Culture Collection (ATCC, USA).
Measurements
Ultraviolet-visible (UV-Vis) absorption spectra were measured by Shimadzu UV-1750. Steady-state fluorescence/phosphorescence and excitation spectra were measured using HitachiF-4600. The lifetime spectrum was carried out on an Edinburgh FLSP920 fluorescence spectrophotometer equipped with microsecond flashlamp (μF900). An ultrasonic cell disruptor (SCIENTZ-II D, JY92-IIN) was used to prepare nanoparticles. Transmission electron microscopy (TEM) was obtained on a JEOL JEM-2100 transmission electron microscope. Scanning electron microscopy (SEM) images were obtained by a (JSM-7800F) scanning electron microscope.
PNPs preparation
The transparent F127 aqueous solution (3 mg mL -1 ) was firstly prepared by dissolving F127 in deionized water. Then DBCz-BT powder (3 mg) was added into F127 aqueous solution under sonication at room temperature for 10 min (SCIENTZ-II D with 30% output). After sonication, the resulting mixture was filtrated with a polyvinylidene fluoride (PVDF) membrane with 0.22 μm millipore to obtain homogenous nanoparticles.
In vitro antimicrobial assays
Bacteria (E. coli and MRSA) were harvested at mid-log phase and collected by centrifugation. The cell pellets were resuspended in PBS to a final concentration of 1×10 5 -1×10 6 colony-forming units (CFU) mL -1 , and cultured with PNPs for 60 min in a 96-well plate. The photodynamic bactericidal activity of PNPs was then determined by being exposed to a light of 410 nm for desired time. In the experiment to explore the relationship of toxicity with incubated concentration (0, 0.2, 0.4 and 0.8 mg mL -1 ) in PBS, cells were irradiated for 8 min and cells without added PNPs were used as a control group. In the experiment to test toxicity of PNPs as a function of light doses in PBS, the concentration of PNPs was 0.8 mg mL -1 and the cells were irradiated for 0, 2, 5 and 10 min, and then put in the dark for 120 min.
Thereafter, the retrieved cells were 10-fold diluted to a series of concentrations for agar plating, and then the plates were incubated for 12-18 h for CFU counting. Three independently prepared samples were used in this assay.
In vitro cytotoxicity determination C2C12 cells (the clonal myoblastic cell line, bought from ATCC) were grown in the Dulbecco's Modified Eagle Medium (DMEM, Invitrogen) with 10% (v/v) fetal bovine serum (FBS), 100 U mL -1 penicillin and 100 μg mL -1 streptomycin and incubated under a humidified atmosphere containing 5% CO 2 at 37°C. Then the C2C12 cells were equally seeded in each well of 96-well plates with a density of around 5000 cells per well. The in vitro cytotoxicity of the PNPs against C2C12 cells was tested using AlamarBlue assay. Specifically, C2C12 cells were incubated in the 96-well plates for 4 h. PNPs were mixed with DMEM so as to let the final concentration be 0.8 mg mL -1 into the well. The cells were cultured for 5 days, and the medium was changed every day. The cell viability was determined by AlamarBlue and LIVE/DEAD assays at day 1, 3 and 5.
Burn wound model
The in vivo animal experiments were approved by Nanjing Servicebio Technology Co., Ltd. China and used under protocols approved by the laboratory animal center of Nanjing Tech University. Specific pathogen-free Sprague-Dawley immune-competent male rats (Harlan, Horst, The Netherlands), 7-9 weeks old (200-220 g weight), were obtained from Nanjing Medical University. The rats were individually raised in cages at a standardized temperature for two days, with Standard rat chow and water supplied ad libitum. Prior to the experiments, a partial thickness burn wound was made on the shaved dorsum of the anesthetized rats by pressing against the rat skin for 6 s with a 1.5 cm diameter brass cylinder heated in a water bath at 90°C for 2 min. A 10 μL aliquot of bacteria solution containing a known number of MRSA (1×10 8 CFU mL -1 ) and PNPs (0.8 mg mL -1 ) were applied topically to the burn wound and cells without added PNPs were used as a control group. 10 min later, the rats were exposed to a light of 410 nm for 10 min. After 1 and 3 days, skin tissue samples from the wound sites were collected for biochemical analysis.
Bacteria load in skin
The skin (0.2 g) was removed aseptically from the rat and homogenized in 2 mL of PBS (0.1 mol L −1 , pH 7.2). The tissue homogenates were serially diluted. Bacteria load was determined by plating the dilution on nutrient agar plates and enumerated in terms of CFU mL -1 . After the bacteria on the skin were freeze-dried, SEM was used to observe the bacteria on the skin surface.
Histologic analysis
On day 3, specimens from all wound sites were harvested, followed by fixing in a 10% buffered formalin solution, and embedded in paraffin, which were used for hematoxylin and eosin (H&E) staining and Masson's trichrome staining.
RESULTS
The metal-free organic phosphor DBCz-BT was synthesized according to our previous studies [58] , which showed red emissive phosphorescence due to both intense intramolecular and intermolecular interactions caused by heavy halogen atoms ( Fig. S1 (Supplementary  information) ). DBCz-BT powders were encapsulated with a triblock copolymer, pluronic F127 (PEG-b-PPG-b-PEG) (Scheme S1). The amphiphilic structure of F127 holds the promise for the formation of aggregation in an aqueous solution with good biocompatibility (Fig. S2) . The welldispersed PNPs possess the ultrasmall size of less than 5 nm observed by TEM ( Fig. 1b ), which will serve as a potential nanoprobe in the bio-application. Moreover, photophysical properties of PNPs in deionized water were fully studied. As shown in Fig. 1c , the excitation spectrum of PNPs reaches 520 nm, which makes the visible-light excitation possible. Compared with ultraviolet light, visible light shows less phototoxicity. The photoluminescence (PL) spectrum of PNPs showed an intense red emission at 600 nm, with emission lifetime as long as 167.29 μs under 410 nm excitation (Fig. 1d ), demonstrating its phosphorescent nature. Surprisingly, the obtained water-soluble PNPs after encapsulation showed similar phosphorescence property as crystalline DBCz-BT, which could be explained by the strong halogen bonding within aggregated nanoparticles (Fig. S1 ). As previously reported, this long lifetime of T 1 state ensured the required bimolecular collision with O 2 for easily occurring energy transfer [59] .
In order to verify the potential bactericidal capacity of PNPs, their 1 O 2 generation capability was determined. The chemical agent, 2,2'-(anthracene-9,10-diylbis(methylene)) dimalonic acid (ADMA) (Scheme S2), was used as a tracker to monitor the production of 1 O 2 [60] . The mixed solution containing PNPs water solution (0.8 mg mL -1 ) and ADMA (50 μg mL -1 ) in a cuvette was excited at 410 nm. The photodegradation of ADMA was presented through absorption spectral quenching under the oxidation of 1 O 2 . As shown in the Fig. 2a , the characteristic absorbance at 260 nm of ADMA decreased faster within 10 min excitation than traditional photosensitizer-zinc(II) phthalocyanine, whose absorbance reduced within 40 min of illumination [60] . And in the inset of Fig. 2a , the absorbance at 260 nm reduced exponentially within 2 min excitation, which revealed an extremely fast generation rate of 1 O 2 , paving a way for the photodynamic antimicrobial.
Furthermore, the in vitro antimicrobial activity of PNPs was evaluated against two pathogenic microbes (Gramnegative bacterium: E. coli; Gram-positive bacterium: MRSA). As shown in Fig. 2b, MRSA Fig. 2c and Fig. S3a , there was little difference between the CFU of experimental group and control group in 0 min of irradiation for the two bacteria (E. coli and MRSA).
Meanwhile, no obvious phototoxicity was found, which can be identified by the nearly constant CFUs of the two bacteria (E. coli and MRSA) in blank control group under different irradiation times. And as the illumination time increases, the number of dead bacteria increases. The bactericidal rate of E. coli reaches almost 100% in 10 min of irradiation, while MRSA in 5 min. Notably, the images of CFUs also showed that no viable bacteria were found for E. coli and MRSA after they were treated with PNPs followed by excitation at 410 nm for 10 min (Fig. 2d and Fig. S2b ). Therefore, PNPs (0.8 mg mL -1 ) showed extremely potent antimicrobial efficacy against the two pathogens and the bacteriostatic rates reached nearly 100% by excitation at 410 nm for 10 min. Aside from good antimicrobial activity, biocompatibility is another criterion to evaluate the feasibility of biomaterials in burn wound infection. The cytotoxicity of PNPs towards mouse cells (C2C12 myoblast cell line) was evaluated with AlamarBlue and LIVE/DEAD cell viability assays. C2C12 cells are derived from the mouse muscle and skin containing muscle tissue, which are precursor cells for the regeneration of muscle tissue after trauma [61] . So C2C12 myoblasts was chosen to evaluate the biocompatibility of the PNPs. The cells were inoculated on the tissue culture polystyrene (TCPS) plate with a density of around 5000 cells per well and incubated for 5 h to permit adherence of cells. Then, the PNPs were added as a treated group; TCPS was used as control. Fig. 3a shows that the cell viability still exceeds 95% in the high concentration of PNPs (0.8 mg mL -1 ) after incubation for 5 days. From Fig. S4 , the fluorescence intensity of cells increased with the incubation time, suggesting that the C2C12 proliferated with the existence of the PNPs. Meanwhile, almost all the cells were stained green after cultivation for 5 days, indicating that they were still alive ( Fig. 3d, e ). Thus, all these results demonstrated that the PNPs with low cytotoxicity and good biocompatibility can be regarded as the photodynamic antibacterial agent for in vivo anti-infection applications.
The MRSA is one of the most common multi-drug resistant bacteria in clinical practice. The photodynamic antimicrobial therapeutic effects of PNPs against MRSA infections were further investigated in the rat MRSA skin burn infection model. Burn infection is a kind of devastating injury that can damage the skin's defense system [62] . Burn infection is one of the most serious complications; 22% deaths of burn patients are related to sepsis from burn wound infections [63] . As shown in Fig. 4a , the back skin of the mouse that received the burn wound infliction and MRSA was used to cause infection, and the treated group further accepted PNPs treatment while the control group did not. Then both groups were put under the visible light irradiation. From the SEM of the skin epidermis, most of the bacteria on the epidermis have been killed for PNPs-treated group after three days (Fig. 4b, c ). The CFUs of MRSA in the skin homogenate at the wound were counted (Fig. 4d ). The bacteria proliferation of PNPs-treated group was well controlled compared with the untreated group (control). Subsequently, histopathological examination was given to observe the wound healing of mouse skin. The anatomy of PNPs-treated mouse skin was compared with that of the untreated group (control). The control group showed largish detachment and breakage of epidermis along with inflammation (dotted portion) ( Fig. 4e ). However, there were intact dermis and epidermis in the skin tissue similar to the normal skin when treated with PNPs formulations (Fig. 4f) . Therefore, the developed PNPs formulation can effectively induce the bacteria death and is considered nonirritant and safe for in vivo anti-infection applications.
DISCUSSION
Since the intrinsic drawback of organometallic phosphors, such as molecular instability, expensive and re- source-limited noble metals, metal-free organic luminogens with room temperature phosphorescence (RTP) are attractive alternatives in bioelectronics. However, most of the traditionally reported RTP materials are limited to bulk materials. The inherent defects of these bulk materials such as brittleness and bulkiness greatly limit their practical application in the bio-medical fields. Besides, the inherent drawbacks of antimicrobials reported previously (including host defense peptides, immunomodulators, bacteriophages, silver nanoagents) like sophistication, high cost, and unpredictable threats to human health (such as cellular toxicity, skin staining, allergic reactions) impeded their biomedical applications. Our work provides a new platform for preparing functional phosphorescence nanoprobes as non-toxic antimicrobial agents with potent biocidal efficacy towards multidrugresistant bacteria, expanding the application scope to biomedical fields. Meanwhile, there is great potential for the organic phosphorescence nanoparticles in the application of bioimaging [2,64]. There is strong background fluorescence interference in the practical bio-applications, giving the chance to use organic phosphorescence nanoparticles with long emission lifetime, time-resolved techniques to effectively eliminate the background fluorescence interference to improve the signal-to-noise ratio of imaging.
CONCLUSIONS
In summary, a type of water-soluble and biocompatible PNPs has been developed for treating microbial infections both in vitro and in vivo. Bright red phosphorescence achieved by strong halogen bonding can be observed in aqueous solution by the naked eye under visible light excitation, which is expected to be applied to bacterial detection through specific light emission. An efficient energy transfer between the PNPs and the ground state of oxygen allows the efficient generation of 1 O 2 , resulting in a potent antimicrobial activity and excellent therapeutic effects in vitro and in vivo. To the best of our knowledge, this is the first example of metal-free organic phosphorescence nanomaterials used in the field of photodynamic antimicrobial. Thus, the visible-light-excited PNPs may provide a new platform for preparing functional phosphorescence nanoprobes and expanding the application scope to biomedical fields.
